Based on literatures [55,56], we believe that genetic susceptibility to SCZ may increase the expression of thyroid-stimulating hormone, which in turn increases the expression of thyroid hormone, thus resulting in patients with SCZ having an increased risk of breast cancer, ovarian cancer, and thyroid cancer. The gene discussed is TG; the disease is ovarian cancer.